Retail & Wholesale » Retail | Pharmarise Holdings Corp.

Pharmarise Holdings Corp. | Cash Flow

Fiscal year is June-May. All values JPY Millions.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,156
943
1,025
1
414
Depreciation, Depletion & Amortization
1,082
1,158
1,199
1,293
1,326
Other Funds
232
733
228
-
-
Funds from Operations
2,006
1,368
1,296
1,252
2,056
Changes in Working Capital
700
2,037
1,569
851
726
Net Operating Cash Flow
1,306
3,405
273
2,103
1,330
Capital Expenditures
885
633
564
576
405
Sale of Fixed Assets & Businesses
10
29
295
3
-
Purchase/Sale of Investments
274
20
79
163
11
Net Investing Cash Flow
1,708
1,064
774
871
527
Cash Dividends Paid - Total
105
126
143
125
126
Issuance/Reduction of Debt, Net
305
1,974
864
690
399
Net Financing Cash Flow
490
2,101
492
816
894
Net Change in Cash
88
240
554
416
91
Free Cash Flow
479
2,786
738
1,540
927
Net Assets from Acquisitions
654
388
401
450
131
Other Sources
358
66
138
210
229
Change in Capital Stock
-
-
901
-
-
Other Uses
263
118
320
219
231

About Pharmarise Holdings

View Profile
Address
Sumitomo Nakano Sakaue Building, 8/F
Tokyo Tokyo 164
Japan
Employees -
Website http://www.pharmarise.com
Updated 07/08/2019
Pharmarise Holdings Corp. engages in the management of its group pharmacies. Its operations are carried out through the Dispensing Pharmacy Business and Others segments. The Dispensing Pharmacy Business segment deals with dispensing medicine to patients under the health insurance system.